TrialCancer medicine2023

An exploratory clinical trial of apatinib combined with intensity-modulated radiation therapy for patients with unresectable hepatocellular carcinoma.

Hu Qiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.